<DOC>
	<DOCNO>NCT00028145</DOCNO>
	<brief_summary>The purpose study collect study clinical laboratory information pregnant new mother medical care increase knowledge best care HIV-infected pregnant woman child . The rate transmission HIV mother infants go . Specific U.S. Public Health Service guideline recommend HIV-infected pregnant woman treat anti-HIV therapy ; effectiveness treatment safety mother infant fully examine . This study monitor health woman infant receive anti-HIV therapy . Also , study provide information may use future study .</brief_summary>
	<brief_title>Prenatal Postnatal Studies Interventions Prevention Mother-To-Child Transmission</brief_title>
	<detailed_description>The current low rate vertical transmission HIV U.S. limit number type question concern transmission risk pathogenesis address single clinical trial . Specific U.S. Public Health Service guideline recommend antiretroviral therapy ( ART ) pregnancy maximize health woman . However , data regard effectiveness safety adherence ART pregnancy limit . It appropriate necessary theInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group ( IMPAACT ) recruit pregnant woman non-interventional , analytic , epidemiologic study methodically collect clinical laboratory data infant . This way , IMPAACT achieve aim evaluate management HIV-infected woman pregnancy determine safety effectiveness ART intervention intend prevent vertical transmission and/or improve maternal health . In addition , longitudinally collect core protocol data repository specimen enable future substudies . Participants receive protocol specific treatment intervention part study . The study involve follow-up HIV-infected woman enrol pregnancy time delivery 6 month postpartum infant first 6 month life . There 8 study visit enrol participant 6 study visit infant . Data concern ART use , adherence medication , review symptom relevant side effect toxicity collect administration questionnaires maternal visit . Phlebotomy conduct obtain specimens repository require laboratory test . During labor delivery , maternal blood obtain lymphocyte subset viral load assay repository storage . Collection amniotic fluid time cesarean section encourage . These collection submit central repository . Data core protocol abstract infant 's medical record time birth postnatal visit .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Pregnancy Complications , Infectious</mesh_term>
	<criteria>HIV infect At least 14 week pregnant OR deliver liveborn stillborn infant within 14 day delivery Currently receive care IMPAACT participate site Have parent guardian willing provide sign informed consent , applicable Mentally capable give informed consent infant self follow IMPAACT site Intend end pregnancy Unable come study visit within 14 day delivery ( know HIV infect prior delivery ) OR within 28 day delivery ( find HIV infected time labor delivery within 14 day delivery )</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Women 's Health</keyword>
	<keyword>Disease Transmission , Vertical</keyword>
	<keyword>Preventive Medicine</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>